BACKGROUND: A prospective longitudinal study to profile patient-reported symptoms during radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) for head and neck cancer was performed. The goals were to understand the onset and trajectory of specific symptoms and their severity, identify clusters, and facilitate symptom interventions and clinical trial design. METHODS: Participants in this questionnaire-based study received RT or CCRT. They completed the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module before and weekly during treatment. Symptom scores were compared between treatment groups, and hierarchical cluster analysis was used to depict clustering of symptoms at treatment end. Variables believed to predict symptom severity were assessed using a multivariate mixed model. RESULTS: Among the 149 patients studied, the majority (47%) had oropharyngeal tumors, and nearly one-half received CCRT. Overall symptom severity (P < .001) and symptom interference (P < .0001) became progressively more severe and were more severe for those receiving CCRT. On multivariate analysis, baseline Eastern Cooperative Oncology Group performance status (P < .001) and receipt of CCRT (P < .04) correlated with higher symptom severity. Fatigue, drowsiness, lack of appetite, problem with mouth/throat mucus, and problem tasting food were more severe for those receiving CCRT. Both local and systemic symptom clusters were identified. CONCLUSIONS: The findings from this prospective longitudinal study identified a pattern of local and systemic symptoms, symptom clusters, and symptom interference that was temporally distinct and marked by increased magnitude and a shift in individual symptom rank order during the treatment course. These inform clinicians about symptom intervention needs, and are a benchmark for future symptom intervention clinical trials.
BACKGROUND: A prospective longitudinal study to profile patient-reported symptoms during radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) for head and neck cancer was performed. The goals were to understand the onset and trajectory of specific symptoms and their severity, identify clusters, and facilitate symptom interventions and clinical trial design. METHODS:Participants in this questionnaire-based study received RT or CCRT. They completed the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module before and weekly during treatment. Symptom scores were compared between treatment groups, and hierarchical cluster analysis was used to depict clustering of symptoms at treatment end. Variables believed to predict symptom severity were assessed using a multivariate mixed model. RESULTS: Among the 149 patients studied, the majority (47%) had oropharyngeal tumors, and nearly one-half received CCRT. Overall symptom severity (P < .001) and symptom interference (P < .0001) became progressively more severe and were more severe for those receiving CCRT. On multivariate analysis, baseline Eastern Cooperative Oncology Group performance status (P < .001) and receipt of CCRT (P < .04) correlated with higher symptom severity. Fatigue, drowsiness, lack of appetite, problem with mouth/throat mucus, and problem tasting food were more severe for those receiving CCRT. Both local and systemic symptom clusters were identified. CONCLUSIONS: The findings from this prospective longitudinal study identified a pattern of local and systemic symptoms, symptom clusters, and symptom interference that was temporally distinct and marked by increased magnitude and a shift in individual symptom rank order during the treatment course. These inform clinicians about symptom intervention needs, and are a benchmark for future symptom intervention clinical trials.
Authors: Carolyn E Schwartz; Rita Bode; Nicholas Repucci; Janine Becker; Mirjam A G Sprangers; Peter M Fayers Journal: Qual Life Res Date: 2006-09-26 Impact factor: 4.147
Authors: David I Rosenthal; Joshua A Asper; Jerry L Barker; Adam S Garden; K S Clifford Chao; William H Morrison; Randal S Weber; K Kian Ang Journal: Head Neck Date: 2006-11 Impact factor: 3.147
Authors: David I Rosenthal; Tito R Mendoza; Mark S Chambers; Joshua A Asper; Ibrahima Gning; Merrill S Kies; Randal S Weber; Jan S Lewin; Adam S Garden; K Kian Ang; Xin S Wang; Charles S Cleeland Journal: Head Neck Date: 2007-10 Impact factor: 3.147
Authors: Dennis C Turk; Robert H Dworkin; Robert R Allen; Nicholas Bellamy; Nancy Brandenburg; Daniel B Carr; Charles Cleeland; Raymond Dionne; John T Farrar; Bradley S Galer; David J Hewitt; Alejandro R Jadad; Nathaniel P Katz; Lynn D Kramer; Donald C Manning; Cynthia G McCormick; Michael P McDermott; Patrick McGrath; Steve Quessy; Bob A Rappaport; James P Robinson; Mike A Royal; Lee Simon; Joseph W Stauffer; Wendy Stein; Jane Tollett; James Witter Journal: Pain Date: 2003-12 Impact factor: 6.961
Authors: David I Rosenthal; Tito R Mendoza; Mark S Chambers; V Shannon Burkett; Adam S Garden; Amy C Hessell; Jan S Lewin; K Kian Ang; Merrill S Kies; Ibrahima Gning; Xin S Wang; Charles S Cleeland Journal: Int J Radiat Oncol Biol Phys Date: 2008-05-22 Impact factor: 7.038
Authors: Terence T Sio; Huei-Kai Lin; Qiuling Shi; G Brandon Gunn; Charles S Cleeland; J Jack Lee; Mike Hernandez; Pierre Blanchard; Nikhil G Thaker; Jack Phan; David I Rosenthal; Adam S Garden; William H Morrison; C David Fuller; Tito R Mendoza; Radhe Mohan; Xin Shelley Wang; Steven J Frank Journal: Int J Radiat Oncol Biol Phys Date: 2016-02-18 Impact factor: 7.038
Authors: Matthew J Ferris; Jim Zhong; Jeffrey M Switchenko; Kristin A Higgins; Richard J Cassidy; Mark W McDonald; Bree R Eaton; Kirtesh R Patel; Conor E Steuer; H Michael Baddour; Andrew H Miller; Deborah W Bruner; Canhua Xiao; Jonathan J Beitler Journal: Radiother Oncol Date: 2017-08-18 Impact factor: 6.280
Authors: Brigid A McDonald; Sastry Vedam; Jinzhong Yang; Jihong Wang; Pamela Castillo; Belinda Lee; Angela Sobremonte; Sara Ahmed; Yao Ding; Abdallah S R Mohamed; Peter Balter; Neil Hughes; Daniela Thorwarth; Marcel Nachbar; Marielle E P Philippens; Chris H J Terhaard; Daniel Zips; Simon Böke; Musaddiq J Awan; John Christodouleas; Clifton D Fuller Journal: Int J Radiat Oncol Biol Phys Date: 2020-12-16 Impact factor: 7.038
Authors: Joshua R Niska; Michele Y Halyard; Angelina D Tan; Pamela J Atherton; Samir H Patel; Jeff A Sloan Journal: Qual Life Res Date: 2017-02-28 Impact factor: 4.147
Authors: Ryan P Goepfert; Jan S Lewin; Martha P Barrow; Carla L Warneke; Clifton D Fuller; Stephen Y Lai; Randal S Weber; Katherine A Hutcheson Journal: Dysphagia Date: 2017-08-23 Impact factor: 3.438
Authors: G Brandon Gunn; Banu Atalar; Tito R Mendoza; Charles S Cleeland; Uğur Selek; Enis Özyar; David I Rosenthal Journal: Balkan Med J Date: 2016-05-01 Impact factor: 2.021
Authors: M de Ridder; Z A R Gouw; J J Sonke; A Navran; B Jasperse; J Heukelom; M E T Tesselaar; W M C Klop; M W M van den Brekel; Abrahim Al-Mamgani Journal: Eur Arch Otorhinolaryngol Date: 2016-12-09 Impact factor: 2.503
Authors: Stuart E Samuels; Yebin Tao; Teresa Lyden; Marc Haxer; Matthew Spector; Kelly M Malloy; Mark E Prince; Carol R Bradford; Francis P Worden; Matthew Schipper; Avraham Eisbruch Journal: Oral Oncol Date: 2016-01-06 Impact factor: 5.337